Octant Bio
Los Angeles
About Octant Bio
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $115.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Apr 2022)
- Website: octant.bio
Industries & Categories
Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/octant-bio-6874 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.